XML 27 R16.htm IDEA: XBRL DOCUMENT v3.25.2
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests
 3 Months Ended
Jul. 31, 2025
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests  
Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests
The following table presents a summary of changes to the liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests:
Stock
Appreciation
Rights		Deferred
Compensation		Redeemable
Noncontrolling
Interests
(in thousands)
Balance as of April 30, 2025$33,249 $1,485 $7,374 
Change in fair value867 15 71 
Balance as of July 31, 2025$34,116 $1,500 $7,445 
Classified as current as of April 30, 2025$20,798 $1,485 $7,374 
Classified as long-term as of April 30, 202512,451 — — 
Classified as current as of July 31, 2025$22,210 $1,500 $7,445 
Classified as long-term as of July 31, 202511,906 — — 
Total expense related to these instruments was $1.0 million and $0.7 million during the three months ended July 31, 2025 and 2024, respectively, and was included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and Comprehensive Income. Current and long-term liabilities for stock appreciation rights, deferred compensation and redeemable noncontrolling interests are included in other accrued expenses and current liabilities and other liabilities, respectively, in the Condensed Consolidated Balance Sheets. See Note 13, “Stock Appreciation Rights, Deferred Compensation and Redeemable Noncontrolling Interests,” in the Company’s Annual Report on Form 10-K for the year ended April 30, 2025 for more information regarding stock appreciation rights, deferred compensation and redeemable noncontrolling interests.